178 related articles for article (PubMed ID: 9715272)
1. Telomerase activity during spontaneous immortalization of Li-Fraumeni syndrome skin fibroblasts.
Gollahon LS; Kraus E; Wu TA; Yim SO; Strong LC; Shay JW; Tainsky MA
Oncogene; 1998 Aug; 17(6):709-17. PubMed ID: 9715272
[TBL] [Abstract][Full Text] [Related]
2. Alterations in p53 and p16INK4 expression and telomere length during spontaneous immortalization of Li-Fraumeni syndrome fibroblasts.
Rogan EM; Bryan TM; Hukku B; Maclean K; Chang AC; Moy EL; Englezou A; Warneford SG; Dalla-Pozza L; Reddel RR
Mol Cell Biol; 1995 Sep; 15(9):4745-53. PubMed ID: 7651392
[TBL] [Abstract][Full Text] [Related]
3. Maintenance of telomeres in SV40-transformed pre-immortal and immortal human fibroblasts.
Small MB; Hubbard K; Pardinas JR; Marcus AM; Dhanaraj SN; Sethi KA
J Cell Physiol; 1996 Sep; 168(3):727-36. PubMed ID: 8816928
[TBL] [Abstract][Full Text] [Related]
4. Immortal, telomerase-negative cell lines derived from a Li-Fraumeni syndrome patient exhibit telomere length variability and chromosomal and minisatellite instabilities.
Tsutsui T; Kumakura S; Tamura Y; Tsutsui TW; Sekiguchi M; Higuchi T; Barrett JC
Carcinogenesis; 2003 May; 24(5):953-65. PubMed ID: 12771041
[TBL] [Abstract][Full Text] [Related]
5. Knockdown of p53 combined with expression of the catalytic subunit of telomerase is sufficient to immortalize primary human ovarian surface epithelial cells.
Yang G; Rosen DG; Mercado-Uribe I; Colacino JA; Mills GB; Bast RC; Zhou C; Liu J
Carcinogenesis; 2007 Jan; 28(1):174-82. PubMed ID: 16829690
[TBL] [Abstract][Full Text] [Related]
6. Telomerase protects cancer-prone human cells from chromosomal instability and spontaneous immortalization.
Elmore LW; Turner KC; Gollahon LS; Landon MR; Jackson-Cook CK; Holt SE
Cancer Biol Ther; 2002; 1(4):391-7. PubMed ID: 12432253
[TBL] [Abstract][Full Text] [Related]
7. Telomerase activity of sarcoma cell lines and fibroblasts is independent of p53 status.
Milas M; Yu D; Sun D; Pollock RE
Clin Cancer Res; 1998 Jun; 4(6):1573-9. PubMed ID: 9626480
[TBL] [Abstract][Full Text] [Related]
8. Stat1 expression is not sufficient to regulate the interferon signaling pathway in cellular immortalization.
Tang L; Roberts PC; Kraniak JM; Li Q; Tainsky MA
J Interferon Cytokine Res; 2006 Jan; 26(1):14-26. PubMed ID: 16426144
[TBL] [Abstract][Full Text] [Related]
9. Association of extended in vitro proliferative potential with loss of p16INK4 expression.
Noble JR; Rogan EM; Neumann AA; Maclean K; Bryan TM; Reddel RR
Oncogene; 1996 Sep; 13(6):1259-68. PubMed ID: 8808700
[TBL] [Abstract][Full Text] [Related]
10. Repression of an alternative mechanism for lengthening of telomeres in somatic cell hybrids.
Perrem K; Bryan TM; Englezou A; Hackl T; Moy EL; Reddel RR
Oncogene; 1999 Jun; 18(22):3383-90. PubMed ID: 10362359
[TBL] [Abstract][Full Text] [Related]
11. Abrogation of wild-type p53-mediated transactivation is insufficient for mutant p53-induced immortalization of normal human mammary epithelial cells.
Cao Y; Gao Q; Wazer DE; Band V
Cancer Res; 1997 Dec; 57(24):5584-9. PubMed ID: 9407971
[TBL] [Abstract][Full Text] [Related]
12. Detection of both mutant and wild-type p53 protein in normal skin fibroblasts and demonstration of a shared 'second hit' on p53 in diverse tumors from a cancer-prone family with Li-Fraumeni syndrome.
Srivastava S; Tong YA; Devadas K; Zou ZQ; Sykes VW; Chen Y; Blattner WA; Pirollo K; Chang EH
Oncogene; 1992 May; 7(5):987-91. PubMed ID: 1373881
[TBL] [Abstract][Full Text] [Related]
13. Analysis of genomic instability in Li-Fraumeni fibroblasts with germline p53 mutations.
Liu PK; Kraus E; Wu TA; Strong LC; Tainsky MA
Oncogene; 1996 Jun; 12(11):2267-78. PubMed ID: 8649766
[TBL] [Abstract][Full Text] [Related]
14. Aberrant p21WAF1-dependent growth arrest as the possible mechanism of abnormal resistance to ultraviolet light cytotoxicity in Li-Fraumeni syndrome fibroblast strains heterozygous for TP53 mutations.
Barley RD; Enns L; Paterson MC; Mirzayans R
Oncogene; 1998 Aug; 17(5):533-43. PubMed ID: 9704919
[TBL] [Abstract][Full Text] [Related]
15. Telomere dynamics, end-to-end fusions and telomerase activation during the human fibroblast immortalization process.
Ducray C; Pommier JP; Martins L; Boussin FD; Sabatier L
Oncogene; 1999 Jul; 18(29):4211-23. PubMed ID: 10435634
[TBL] [Abstract][Full Text] [Related]
16. Immortalization in a normal foreskin fibroblast culture following transduction of cyclin A2 or cdk1 genes in retroviral vectors.
Luo P; Tresini M; Cristofalo V; Chen X; Saulewicz A; Gray MD; Banker DE; Klingelhutz AL; Ohtsubo M; Takihara Y; Norwood TH
Exp Cell Res; 2004 Apr; 294(2):406-19. PubMed ID: 15023530
[TBL] [Abstract][Full Text] [Related]
17. Stepwise neoplastic transformation of a telomerase immortalized fibroblast cell line.
Zongaro S; de Stanchina E; Colombo T; D'Incalci M; Giulotto E; Mondello C
Cancer Res; 2005 Dec; 65(24):11411-8. PubMed ID: 16357149
[TBL] [Abstract][Full Text] [Related]
18. Functional studies of a novel germline p53 splicing mutation identified in a patient with Li-Fraumeni-like syndrome.
Piao J; Sakurai N; Iwamoto S; Nishioka J; Nakatani K; Komada Y; Mizutani S; Takagi M
Mol Carcinog; 2013 Oct; 52(10):770-6. PubMed ID: 22495821
[TBL] [Abstract][Full Text] [Related]
19. Telomerase activation in human fibroblasts during escape from crisis.
Montalto MC; Phillips JS; Ray FA
J Cell Physiol; 1999 Jul; 180(1):46-52. PubMed ID: 10362016
[TBL] [Abstract][Full Text] [Related]
20. Effects of chemopreventive and antitelomerase agents on the spontaneous immortalization of breast epithelial cells.
Herbert BS; Wright AC; Passons CM; Wright WE; Ali IU; Kopelovich L; Shay JW
J Natl Cancer Inst; 2001 Jan; 93(1):39-45. PubMed ID: 11136840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
